Status:
COMPLETED
A Study for Leukemia Patients With Life-Threatening Infections
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Leukemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The goal of this clinical research study is to compare the effectiveness of a white blood cell transfusion with radiated cells to a white blood cell transfusion with cells that have not been radiated....
Detailed Description
Radiated White Blood Cell Transfusions: White blood cell transfusions from a volunteer donor may contain blood cells that your body can react with to produce a disorder called transfusion-associated ...
Eligibility Criteria
Inclusion
- Diagnosis of hematologic malignancy admitted to the Leukemia service.
- Severe neutropenia defined as Absolute neutrophil count (ANC) less than or equal to 1000.
- Persistent fever and/or signs of life threatening infection despite 48 hours on antibiotics.
- Sign a written informed consent form.
- Greater than 18 years of age.
Exclusion
- 1\) None
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT00968838
Start Date
April 1 2009
End Date
August 1 2011
Last Update
November 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030